Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Cerchietti Research Lab
Explore this Website
Home
Research
Toggle Research menu options
Projects
Lab Team
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
Research
Lab Team
Publications
News
Home
Publications
Publications
Found 9 results
Author
Title
Type
Year
Filters:
Author
is
Hatzi, Katerina
[Clear All Filters]
2017
Valls E
,
Lobry C
,
Geng H
,
Wang L
,
Cardenas M
,
Rivas M
,
Cerchietti L
,
Oh P
,
Yang SNing
,
Oswald E
et al.
. 2017.
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
.
Cancer Discov.
2016
Cardenas MG
,
Yu W
,
Beguelin W
,
Teater MR
,
Geng H
,
Goldstein RL
,
Oswald E
,
Hatzi K
,
Yang S-N
,
Cohen J
et al.
. 2016.
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
.
J Clin Invest.
Dupont T
,
Yang SNing
,
Patel J
,
Hatzi K
,
Malik A
,
Tam W
,
Martin P
,
Leonard J
,
Melnick A
,
Cerchietti L
. 2016.
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
.
Oncotarget. 7(3):3520-32.
2013
Hatzi K
,
Jiang Y
,
Huang C
,
Garrett-Bakelman F
,
Gearhart MD
,
Giannopoulou EG
,
Zumbo P
,
Kirouac K
,
Bhaskara S
,
Polo JM
et al.
. 2013.
A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.
.
Cell Rep. 4(3):578-88.
2011
Moulick K
,
Ahn JH
,
Zong H
,
Rodina A
,
Cerchietti L
,
DaGama EMGomes
,
Caldas-Lopes E
,
Beebe K
,
Perna F
,
Hatzi K
et al.
. 2011.
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.
.
Nat Chem Biol. 7(11):818-26.
Hurtz C
,
Hatzi K
,
Cerchietti L
,
Braig M
,
Park E
,
Kim Y-mi
,
Herzog S
,
Ramezani-Rad P
,
Jumaa H
,
Müller MC
et al.
. 2011.
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia.
.
J Exp Med. 208(11):2163-74.
2010
Cerchietti LC
,
Hatzi K
,
Caldas-Lopes E
,
Yang SNing
,
Figueroa ME
,
Morin RD
,
Hirst M
,
Mendez L
,
Shaknovich R
,
Cole PA
et al.
. 2010.
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy.
.
J Clin Invest. 120(12):4569-82.
2009
Cerchietti LC
,
Yang SNing
,
Shaknovich R
,
Hatzi K
,
Polo JM
,
Chadburn A
,
Dowdy SF
,
Melnick A
. 2009.
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo.
.
Blood. 113(15):3397-405.
Cerchietti LC
,
Lopes EC
,
Yang SNing
,
Hatzi K
,
Bunting KL
,
Tsikitas LA
,
Mallik A
,
Robles AI
,
Walling J
,
Varticovski L
et al.
. 2009.
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.
.
Nat Med. 15(12):1369-76.